Timmerman, Luke,
Practical Geniuses of Technology--Methodical Man: Ken Mohler. Luke Timmerman. - The Seattle Times, 2004. - SIRS Enduring Issues 2005. Article 73, Science, 1522-3264; .
Articles Contained in SIRS Enduring Issues 2005. Originally Published: Practical Geniuses of Technology--Methodical Man: Ken Mohler, May 5, 2004; pp. n.p..
"Ken Mohler grew up a doctor's son in the Kansas cow town of Abilene. He liked the idea of helping patients--except when doctors felt helpless, out of treatment options. He was more attracted to the can-do mentality of his grandfather, an entrepreneur, and finding ways to apply it to medicine. It took most of his life to do it, starting with years of study in immunology and then a low-level job in a pharmaceutical company, but he found a way. Mohler is one of the few scientists of his generation who has created a breakthrough drug that has enabled bedridden patients to return to their jobs, or play golf, without pain. Mohler, 48, did it at Immunex, one of Seattle's pioneering biotechnology companies, and now runs research and development at a startup, Trubion Pharmaceuticals in Seattle." (THE SEATTLE TIMES) This article examines the work of a scientist whose research led to the relief of pain and suffering for thousands of sufferers of inflammatory diseases such as rheumatoid arthritis.
1522-3264;
Mohler, Ken
Enbrel
Inflammation
Medicine--Research
Rheumatoid arthritis--Treatment
AC1.S5
050
Practical Geniuses of Technology--Methodical Man: Ken Mohler. Luke Timmerman. - The Seattle Times, 2004. - SIRS Enduring Issues 2005. Article 73, Science, 1522-3264; .
Articles Contained in SIRS Enduring Issues 2005. Originally Published: Practical Geniuses of Technology--Methodical Man: Ken Mohler, May 5, 2004; pp. n.p..
"Ken Mohler grew up a doctor's son in the Kansas cow town of Abilene. He liked the idea of helping patients--except when doctors felt helpless, out of treatment options. He was more attracted to the can-do mentality of his grandfather, an entrepreneur, and finding ways to apply it to medicine. It took most of his life to do it, starting with years of study in immunology and then a low-level job in a pharmaceutical company, but he found a way. Mohler is one of the few scientists of his generation who has created a breakthrough drug that has enabled bedridden patients to return to their jobs, or play golf, without pain. Mohler, 48, did it at Immunex, one of Seattle's pioneering biotechnology companies, and now runs research and development at a startup, Trubion Pharmaceuticals in Seattle." (THE SEATTLE TIMES) This article examines the work of a scientist whose research led to the relief of pain and suffering for thousands of sufferers of inflammatory diseases such as rheumatoid arthritis.
1522-3264;
Mohler, Ken
Enbrel
Inflammation
Medicine--Research
Rheumatoid arthritis--Treatment
AC1.S5
050